Duloxetine sprinkles
US10016391B2 · kind B2 · utility
0Cited by
4References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 7, 2017 |
| Grant date | Jul 10, 2018 |
| Priority date | — |
| Expiry date | Nov 7, 2037 |
Classification
- Technology area (CPC —)General
Abstract
The present invention relates in part a to multiparticulate sprinkle dosage form comprising duloxetine or a pharmaceutically acceptable salt thereof, having higher acid resistance as compared to commercially available delayed release formulations. It further relates to various methods of administering the said multiparticulate sprinkle dosage forms.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.